Metformin Vitabalans

Metformin Hydrochloride, the active ingredient in Metformin Vitabalans, is a Biguanide presented as an oral tablet for oral use. It treats type 2 diabetes mellitus in adults by improving blood glucose control. GNH USA supplies Metformin Vitabalans as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Metformin Vitabalans belongs to the biguanide class and is used to manage hyperglycaemia in the type 2 diabetes pathway. - Type 2 diabetes mellitus: improves glycaemic control and reduces fasting plasma glucose levels. - Prediabetes (impaired fasting glucose): helps delay progression to overt diabetes when prescribed by a clinician. - Polycystic ovary syndrome (off‑label, clinician‑guided): may improve insulin resistance and menstrual regularity.

Metformin Vitabalans may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Diarrhoea: loose stools, often early in therapy. - Abdominal discomfort: cramping or bloating. - Metallic taste: transient alteration of taste perception. - Loss of appetite: reduced desire to eat. - Vitamin B12 deficiency: may develop with long‑term use.

Serious or Rare Side Effects: - Lactic acidosis: rare but life‑threatening metabolic acidosis. - Severe skin reactions: such as Stevens‑Johnson syndrome. - Hepatic failure: marked liver enzyme elevation. - Hypoglycaemia: when combined with insulin or sulfonylureas. - Acute pancreatitis: very uncommon. - Anemia: due to folate or B12 deficiency.

Metformin Vitabalans requires careful monitoring and patient education to minimise risks. - Renal function: assess creatinine clearance before initiation and periodically thereafter. - Hepatic function: avoid in patients with significant liver disease. - Lactic acidosis risk: discontinue before any iodinated contrast studies. - Vitamin B12 monitoring: check levels during long‑term therapy. - Pregnancy and lactation: use only if clearly needed after risk‑benefit assessment. - Store at ambient temperature: keep below 25 °C, retain in original packaging, protect from moisture.

Metformin Vitabalans can interact with several medicines, altering its efficacy or safety profile.

Major Interactions (Avoid): - Iodinated contrast agents (IV): increase risk of lactic acidosis; withhold metformin before and after the procedure. - Cimetidine: may raise metformin plasma concentrations. - Alcohol excess: potentiates lactic acidosis risk.

Moderate Interactions (Monitor Closely): - Beta‑blockers: may mask hypoglycaemia symptoms. - Thiazide diuretics: can increase plasma glucose levels. - Corticosteroids: may reduce metformin effectiveness. - ACE inhibitors/ARBs: monitor renal function and potassium.